/PRNewswire/ Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer,.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
Qilian International Holding Group LimitedFebruary 11, 2021 GMT
Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced its financial results for the fiscal year ended September 30, 2020.
Mr. Zhanchang Xin, Chairman and CEO of the Company, commented: “We are pleased with our fiscal year 2020 financial results as we recorded revenue of US$50 million, which was in line with our expectations. The past year was a difficult year for our Company due to the challenges of COVID-19 pandemic, but we continued to grow our business, execute on our strategic priorities, and deliver value to our partners, customers and shareholders. It demonstrates that we have th
ATIF Holdings Limited Releases Letter to Shareholders From The CEO and Director of The Board
News provided by
Share this article
Share this article
LOS ANGELES, Feb. 10, 2021 /PRNewswire/ ATIF Holdings Limited (Nasdaq: ATIF, the Group , ATIF or we ), a holding group providing business and financial consulting in Asia and North America, today released a letter to shareholders from the Chief Executive Officer and Director of the Company s board of directors.
Dear shareholders,
The 2020 COVID-19 global pandemic has brought negative impact and challenges to everyone. However, it brought opportunities for ATIF to think deeply about our development and to adjust ourselves to excel in light of the difficult time due to the pandemic. In reviewing our performance, we strive to continue to serve our customers in light of adversity, and had strategically transformed our business model to launch new main business sectors with high growth potential.
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company will complete the first phase expansion of its new organic fertilizer production facility and put it into production in Jiuquan City, Gansu Province by March 2021. The Company expects to triple its organic fertilizer production capacity upon completion of its first phase expansion. Currently, the Company’s organic fertilizer products are mainly sold to the China’s five northwestern provincial-level regions, namely Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang and other regions including Sichuan, Shanxi, Tibet and Inner Mongolia. With a tripled production capacity, the Company has won bids for government organic fertilizer projects in Tibet, Gansu and Qinghai. After completing the first phase expansion, the Company will mainly focus on producing
Qilian International Holding Group Limited Announces Closing of Initial Public Offering Qilian International Holding Group Limited
Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the closing of its initial public offering ( Offering ) of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.
The Company received aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The ordinary shares began trading on the Nasdaq Global Market on January 12, 2021 under the ticker symbol “QLI”.